Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, T-cell non-Hodgkin lymphoma, acute biphenotypic leukemia, acute leukemia, acute myeloid leukemia, acute undifferentiated leukemia, anemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm, primary cutaneous T-cell non-Hodgkin lymphomaActive, not recruitingPhase 1 / Phase 22026-09-10NCT05589896

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Ossium Health, Inc.6

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Emory University - Winship Cancer InstituteAtlantaUnited States11
Henry Ford Cancer InstituteDetroitUnited States18
Methodist Hospital, Texas TransplantSan AntonioUnited States1
Moffitt Cancer CenterTampaUnited States523
Oregon Health and Science UniversityPortlandUnited States382
St. David's South Austin Medical CenterAustinUnited States1
TriStar Bone Marrow TransplantNashvilleUnited States8
University of Utah - Huntsman Cancer InstituteSalt Lake CityUnited States12